Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells

Blood Adv. 2024 Nov 26;8(22):5880-5884. doi: 10.1182/bloodadvances.2024012762.
No abstract available